BioSpace News Archive

Data on Use of Mallinckrodt’s H.P. Acthar® Gel (Repository Corticotropin Injection) in Patients with Rare Cause of Nephrotic Syndrome Published in Transplantation

First analysis to evaluate H.P. Acthar Gel for focal segmental glomerular sclerosis (FSGS) in kidney transplant recipients

January 3, 2019
·
12 min read
Business

UroGen Pharma Appoints Elizabeth (Liz) Barrett as President and Chief Executive Officer

Ms. Barrett Most Recently Served as CEO for Novartis Oncology and Brings a Track Record of Success in Commercial Oncology

January 3, 2019
·
6 min read
Policy

Merck’s KEYTRUDA® (pembrolizumab) Receives Five New Approvals in Japan, Including in Advanced Non-Small Cell Lung Cancer (NSCLC), as Adjuvant Therapy for Melanoma, and in Advanced Microsatellite Instability-High (MSI-H) Tumors

Merck announced today that KEYTRUDA, Merck’s anti-PD-1 therapy, has simultaneously received five new approvals from the Japan Pharmaceuticals and Medical Devices Agency (PMDA), including three expanded uses in advanced non-small lung cancer (NSCLC), one in melanoma, as well as a new indication in advanced microsatellite instability-high (MSI-H) tumors.

January 3, 2019
·
29 min read
Drug Development

Synthetic Biologics Announces First Two Patients Enrolled in Phase 2b Investigator-Sponsored

Clinical Study of SYN-010, for the Treatment of IBS-C

January 3, 2019
·
8 min read
Business

ImaginAb Announces Immuno-Oncology License and Clinical Trial Collaboration with Nektar Therapeutics

Nektar will use ImaginAb’s CD8 ImmunoPET technology to accelerate the development of its investigational immuno-oncology medicines

January 3, 2019
·
3 min read
Business

Tragara Pharmaceuticals Appoints Scott Megaffin as Chief Executive Officer and Changes Name to Adastra Pharmaceuticals

Company Well-Positioned for Next Phase of Clinical Advancement with Lead Oral Drug Candidate, TG02, for Treatment of Adult and Pediatric Brain Cancers

January 3, 2019
·
4 min read
Job Trends

Luster 365 Offers A Full Year of Professional Grade Teeth Whitening at Home

Make 2019 your brightest year with this 12-product, value-priced bundle

January 3, 2019
·
2 min read
Business

GENFIT and LabCorp Sign a Licensing Agreement to Expand Access to an Innovative Diagnostic Assay for Non-Alcoholic Steatohepatitis (NASH)

Multi-Biomarker Test Will Provide the Clinical Research Community with a Non-Invasive Tool to Identify and Monitor Patients with NASH and Significant Fibrosis

January 3, 2019
·
8 min read
Policy

MYOS RENS Technology Receives a New Patent from the United States Patent and Trademark Office

New Patent Will Significantly Enhance its Fortetropin® Intellectual Property Portfolio

January 3, 2019
·
4 min read
Policy

Aadi Bioscience Receives Breakthrough Therapy Designation for TARZIFYX™ (ABI-009) in PEComa Indication

Lead Registration study in Advanced Malignant PEComa completes enrollment and company is On-Track for 2019 NDA Filing

January 3, 2019
·
4 min read